Plunkett Research Online: Depomed Inc

DEPOMED INC (DEPO) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Depomed, Inc. focuses on pain and other conditions and diseases of the central nervous system (CNS). Products that comprise its specialty pharmaceutical business include Gralise (gabapentin), for the management of postherpetic neuralgia; CAMBIA, a non-steroid anti-inflammatory drug for the acute tr.....


DEPOMED INC

Ticker: DEPO
Exchange: NAS
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 510-744-8000
Fax: 650 462-9993
Address: 7999 Gatewat Blvd., Ste. 300
Newark, CA 94560 United States

Types Of Business
Industry Ranks

Industry NAICS code:

ContactsDescription

August MorettiCFO/Chief Accounting Officer/Senior VP
James FogartyChairman of the Board/Director
See More
Depomed, Inc. focuses on pain and other conditions and diseases of the central nervous system (CNS). Products that comprise its specialty pharmaceutical business include Gralise (gabapentin), for the management of postherpetic neuralgia; CAMBIA, a non-steroid anti-inflammatory drug for the acute tr.....See More See More

$USD, In whole numbers 2017201620152014201320122011
Sales
Profits
Brands, Divisions and AffiliatesTop Salaries
Salary
Bonus
Other ThoughtsCorporate Culture

Employees receive medical and dental coverage, a free gym membership, flexible spending accounts and life insurance.